Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/2008
11/19/2008EP1991710A2 Method for screening hiv drug sensitivity
11/19/2008EP1991709A2 Pseudoinfectious flavivirus and uses thereof
11/19/2008EP1991261A2 Filamentous bacteriophage displaying protein as a binder of antibodies and immunocomplexes for delivery to the brain
11/19/2008CN101307330A BA46 recombinant adeno-associated virus, construction process thereof and applications
11/19/2008CN101307329A Her-2/neu recombinant adeno-associated virus, construction process thereof and applications
11/19/2008CN101307328A CK19 recombinant adeno-associated virus, construction process thereof and applications
11/19/2008CN101307327A CEA recombinant adeno-associated virus, construction process thereof and applications
11/19/2008CN101307326A PSA recombinant adeno-associated virus, construction process thereof and applications
11/19/2008CN101307325A PSMA recombinant adeno-associated virus, construction process thereof and applications
11/19/2008CN101307314A Method for constructing and preparing vaccine against type 2 diabetes mellitus
11/19/2008CN101307305A Low virulent strain of porcine reproductive and respiratory syndrome virus, immunogenicity immunogenicity material and vaccine
11/19/2008CN101306199A Method for producing and purifying hepatitis a inactivated vaccine
11/19/2008CN101306198A NR2B recombinant adenovirus vaccine
11/18/2008US7452710 Process for the biological production of 1,3-propanediol with high titer
11/18/2008US7452709 Method of screening prion disease infection factor
11/18/2008US7452542 Live attenuated coronavirus vaccines
11/18/2008CA2437201C Methods and compositions useful for stimulating an immune response
11/18/2008CA2361565C Synthesis of ethyleneimine dimer
11/18/2008CA2331404C Methods and apparatus for inactivating contaminants in biological fluid
11/18/2008CA2330837C A vector expressing an rna viral full-length gene and its use
11/18/2008CA1341585C Recombinant retroviruses
11/13/2008WO2008137981A1 Human parainfluenza viruses having separated p and c genes
11/13/2008WO2008137163A1 Two-component genome flavivirus and uses thereof
11/13/2008WO2008136470A1 Hcv gene
11/13/2008WO2008135230A1 Two-step temperature profile for the propagation of viruses
11/13/2008WO2008134935A1 Truncated human papillomavirus type 18 l1 proteins
11/13/2008WO2008134934A1 A truncated l1 protein of human papillomavirus 16
11/13/2008WO2008134878A1 Compositions and methods for cancer treatment
11/13/2008WO2008110579A3 Adenovirus with mutations in the endoplasmic reticulum retention domain of the e3-19k protein and their use in cancer treatment.
11/13/2008WO2008076915A3 Treatment of pigs with pcv2 antigen
11/13/2008WO2008035210A3 Recombinant hbsag virus-like particles containing polyepitopes of interest, their production and use
11/13/2008WO2008020331A3 Polynucleotides allowing the expression and secretion of recombinant hepatitis b surface antigen (hbsag) virus-like particles containing a foreign peptide, their production and use
11/13/2008WO2005072129A3 Production of host cells containing mutiple integrating vectors by serial transduction
11/13/2008US20080280363 Pseudotyped Baculovirus and its Use
11/13/2008US20080280354 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
11/13/2008US20080279892 Attenuation of respiratory syncytial virus by mutagenisi of M2-1 gene; immunogenic composition
11/13/2008US20080279891 Viral Adjuvants
11/13/2008US20080279890 Viral antigens
11/13/2008US20080279888 Genetically engineered cell lines and systems for propagating varicella zoster virus and methods of use thereof
11/13/2008US20080279887 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug.
11/13/2008US20080279878 Compositions of Hsp60 Peptides and Viral Antigens for Vaccination and Diagnosis
11/13/2008CA2692815A1 Hcv gene
11/13/2008CA2687122A1 Two-step temperature profile for the propagation of viruses
11/13/2008CA2687119A1 Formulation of sugar solutions for continuous ultracentrifugation for virus purification
11/13/2008CA2686398A1 Two-component genome flavivirus and uses thereof
11/12/2008EP1990409A2 Bacteriophage
11/12/2008EP1989316A2 Method for the production of recombinant virus, dna constructs, recombinant virus and vaccine compositions
11/12/2008EP1523582B1 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same
11/12/2008EP1109892B1 Methods for generating high titer helper-free preparations of released recombinant aav vectors
11/12/2008EP0850313B1 Improved aav vectors for gene therapy
11/12/2008CN101304761A Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms
11/12/2008CN101302536A Virus envelope vector for gene transfer
11/12/2008CN101302500A Vaccine
11/12/2008CN101302499A Preparation of influenza virus vaccine seed strain
11/12/2008CN101302498A Preservation method of mycobacteriophage
11/12/2008CN100432096C Transfer factor specific for SARS virus and method for preparing same
11/11/2008US7449562 Porcine endogenous retrovirus genomic sequences for use as tool in detection of viral infection in xenograft tissue; tissue engineering and organ grafting/transplantation
11/11/2008US7449324 Determining in a sample of an animal the presence of a viral component by reacting the sample with a nucleic acid or an antibody reactive with component of an avian pneumovirus, and crossreactive with a component of MPV (metapneumovirus)
11/11/2008US7449323 immunizing a cat with vaccine against a hemorrhagic feline calicivirus (hFCV); veterinary medicine
11/11/2008US7449322 Avian leukosis viruses and polypeptide display
11/11/2008US7449321 Controlling a flavivirus entry into a cell by administering to the cell an agent functionally interfering with a flavivirus receptor protein, the flavivirus receptor protein being an integrin
11/11/2008US7449288 Determining whether a gp48 protein-specific reagent binds to a gp48 Bovine Viral Diarrhea Virus protein or protein fragment, which retain antigenic specificity, from a target animal's tissue sample
11/06/2008WO2008103920A3 Targeted protein cages
11/06/2008WO2008100290A3 Recombinant rhinovirus vectors
11/06/2008US20080274535 Hepatocyte Bioreactor System For Long Term Culture of Functional Hepatocyte Spheroids
11/06/2008US20080274534 Virus Filtration of Liquid Factor VII Compositions
11/06/2008US20080274533 Liposome carriers for use in enhancing vaccine development
11/06/2008US20080274142 Hinge (hydrophobic pocket) region mutation attenuation; decreased viscerotropism; vaccines
11/06/2008US20080274141 Animal cells and processes for the replication of influenza viruses
11/06/2008US20080274138 leads to higher yields and reduces unwanted aggregation of the virus or virus antigen by increasing the volume of the peak pool
11/06/2008US20080274125 Human Stem Cell Lines Derived From Es Cells and Uses for Production of Vaccines and Recombinant Proteins
11/06/2008US20080274083 Antiviral Resistance Mutants and Applications Thereof
11/06/2008CA2676808A1 Induction of dendritic cell development with macrophage-colony stimulating factor (m-csf)
11/05/2008EP1986686A2 A dengue reporter virus and methods of making and using the same
11/05/2008EP1363937B1 Immunomodulating agents from parasitic worms and method for isolation thereof
11/05/2008EP0994724B1 Methods and compositions for impairing multiplication of hiv-1
11/05/2008CN101300026A Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications
11/05/2008CN100430476C Tumor-lysing virus growing selectively in tumor cells
11/05/2008CN100430475C Alga-origin promoter, intron and terminator
11/04/2008US7446191 Expression vector comprising nucleotide sequences coding t-cell receptor for use in generation of monoclonal antibody for treatement of cell proliferative disorders
11/04/2008US7446177 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
11/04/2008US7445930 Method for the production and purification of adenoviral vectors
11/04/2008US7445929 Recombinant adenovirus vector having a reduced side effect
11/04/2008US7445928 Bacterial artificial chromosome construct encoding recombinant coronavirus
11/04/2008US7445924 Modified Vaccinia Ankara virus variant and cultivation method
11/04/2008US7445889 Western blot or enzyme-linked immunosorbent assay kit for detecting antibodies; stratifying based on signs, symptoms, severity, duration
11/04/2008US7445787 Veterinary medicine; brain disorders; immunizing with vaccine comprising West Nile virus or plasmid DNA, an adjuvant such as a metabolizable oil carrier
10/2008
10/30/2008WO2008129971A1 Improved persistently infective sendai virus vector
10/30/2008WO2008128440A1 A series of recombinant adeno-associated viral vectors, construction methods and uses thereof
10/30/2008WO2008092854A3 Papillomavirus e2 polypeptide used for vaccination
10/30/2008WO2008078198A3 Cells and methodology to generate non-segmented negative-strand rna viruses
10/30/2008US20080269473 Expression vector comprising nucleotide sequences coding gag and pol proteins for as tool in improving exogenous gene expression
10/30/2008US20080268522 Lentiviral packaging constructs
10/30/2008US20080268519 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
10/30/2008US20080268518 Non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, therapeutic, diagnostic, and other biotechnology uses
10/30/2008US20080268514 Liquid matrix dissolved or dissociated in biocompatible solvent and stabilizer in contact without refrigeration for one day
10/30/2008US20080268423 Using immobilized envelope protein domain as tools to identify immunoglobulins generate in response to tick borne encephalitis viral and/or west nile viral infections
10/30/2008US20080267997 Modified Viral Particles with Immunogenic Properties and Reduced Lipid Content Useful for Treating and Preventing Infectious Diseases
10/30/2008US20080267996 Compositions for inducing an immune response against hepatitis B
10/30/2008US20080267989 Self aggregating monomeric fusion protein for use in induction of immune response to human immunodeficiency viral infection
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 267